Literature DB >> 17267474

Gold nanoparticles: a new X-ray contrast agent.

M Geso.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17267474     DOI： 10.1259/bjr/28250432

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  7 in total

Review 1.  Molecular imaging with theranostic nanoparticles.

Authors:  Jesse V Jokerst; Sanjiv S Gambhir
Journal:  Acc Chem Res       Date:  2011-09-15       Impact factor: 22.384

2.  Gold nanoparticle contrast in a phantom and juvenile swine: models for molecular imaging of human organs using x-ray computed tomography.

Authors:  Evan Boote; Genevieve Fent; Vijaya Kattumuri; Stan Casteel; Kavita Katti; Nripen Chanda; Raghuraman Kannan; Kattesh Katti; Robert Churchill
Journal:  Acad Radiol       Date:  2010-04       Impact factor: 3.173

Review 3.  Nanoparticle PEGylation for imaging and therapy.

Authors:  Jesse V Jokerst; Tatsiana Lobovkina; Richard N Zare; Sanjiv S Gambhir
Journal:  Nanomedicine (Lond)       Date:  2011-06       Impact factor: 5.307

4.  A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity.

Authors:  Sanjib Bhattacharyya; Maria Gonzalez; J David Robertson; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Chem Commun (Camb)       Date:  2011-06-30       Impact factor: 6.222

5.  Nanomaterials incorporated ultrasound contrast agents for cancer theranostics.

Authors:  Lei Fu; Heng-Te Ke
Journal:  Cancer Biol Med       Date:  2016-09       Impact factor: 4.248

6.  Highly Biocompatible Nanoparticles of Au@Fluorescent Polymers as Novel Contrast Agent for In Vivo Bimodality NIR Fluorescence/CT Imaging.

Authors:  Mengshu Zhang; Jinlei Liu; Guannan Wang
Journal:  Contrast Media Mol Imaging       Date:  2019-06-10       Impact factor: 3.161

7.  Novel Biocompatible Au Nanostars@PEG Nanoparticles for In Vivo CT Imaging and Renal Clearance Properties.

Authors:  Daiyuan Tang; Wei Gao; Yajiang Yuan; Lingling Guo; Xifan Mei
Journal:  Nanoscale Res Lett       Date:  2017-10-12       Impact factor: 4.703
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.